| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  Aenitis Technologies Acoustic Cell Processing Solution 🚀 Aenitis designs, develops, and markets sole-in-class acoustofluidic technology that makes cell and gene therapy manufacturing better, safer, and less expensive. By precisely controlling levitated cells with sound waves, our systems handle cells in full sterile conditions and radically increase productivity while preserving the native state of cells at every step of the engineering process. This technology enables gentle, non-invasive manipulation of cells at the millifluidic scale, allowing for the handling of tens of milliliters per minute. Such capabilities are critical for scaling applications from research to clinical and industrial use. 💡Today, we have achieved proof-of-concepts … 18 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 31 | 16 |
 | GC Therapeutics A Path to SuperCellsTM Therapies GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCellsTM by tailoring cells for specific diseases. The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients. 73 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 1 | 43 |
 | MarraBio Building Better Biology At MarraBio we design, engineer and construct bacterial protein polymers, that contain the biological messages that cells need to grow, divide and behave properly. Cells grown on an industrial scale for research, agricultural or therapeutic use need to be supplied with the right signals. We provide a multi-functional, cost effective solution in a single, easy to use material. Find out more at https://www.marrabio.com/ Protein Engineering, Protein Production, Cellular Agriculture, Cultivated Meat, Research Reagents, Stem Cell Expansion, and Industrial Scale Cell Culture 137 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 9 |
 | 3Biotech From research to patients: safer, smarter, faster. 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidates. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Our Three Pillars are: 1.Safety 2. Efficacy 3. Manufacturing These are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan of execution. We have implemented a human and customer centric organization to provide the best … 65 similar entities Type: NGO, Think-tanks, Ed, & Culture Startup Activities: biotech deeptech fintech manufacturing regtech Technologies: Synthetic Biology | 3 | 4 |
 | UroGen Pharma UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery technology has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment. Our promising pipeline: Ranging from … 6 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 313 |
 |  Cerba Research Transforming Research, Advancing Health Together At Cerba Research we provide world-class clinical research to help life science companies successfully develop the predictive and precision medicines of the future and help people live healthier lives. We are committed to delivering the next generation of healthcare by transforming research and advancing health together. We support you with industry-leading excellence in oncology, virology, vaccine development, immunology, and cell and gene therapy, together with world-class deep specialty testing, from next generation sequencing to flow cytometry, molecular diagnostics, IHC & and spatial Omics, and bioinformatics. We are committed to helping you deliver the next generation … 76 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Data Analytics Synthetic Biology | 5 | 604 |
 | JURA Bio, Inc. Building the future of AI drug development with the data that matters. CAR-T is for more than just oncology. Using the full potential of gene editing, we are creating a therapeutic platform for cell based therapies that are not just disease modifying: they are curative and definitive. Cell-based Therapies and Machine Learning 115 similar entities Type: Startup Activities: biotech healthtech deeptech Technologies: Synthetic Biology SaaS A.I. Generative A.I. | 2 | 15 |
 | 4P-Pharma Transforming science into drug success stories Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly. Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty. We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible. Translational research, Biotechnology, Pharmaceuticals, … 167 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 31 | 30 |
 | POLYGON Therapeutics Innovation. Applied. Bringing life to life. POLYGON Therapeutics aims to address unmet therapeutic needs through innovative breakthrough approaches. Within its first therapeutic development program EMOTION, POLYGON aspires to transform cardiovascular diseases care. 22 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 17 | 11 |
 | Sahajanand Medical Technologies Pledged to save millions At SMT (Sahajanand Medical Technologies), we are revolutionizing healthcare through innovation and clinical excellence. As a multinational MedTech company with diversified manufacturing facilities and operations across multiple countries, SMT is at the forefront of high-end cardiovascular, endovascular, and structural heart devices. Guided by our mission, “Pledged to Save Millions,” we specialize in developing clinically proven solutions for coronary interventions, occluders for congenital defects, and structural heart therapies. Our products undergo rigorous clinical trials and are featured in world-class medical journals like The Lancet, New England Journal of Medicine, BMJ Open, and JACC, cementing our position as … 61 similar entities Type: SMB Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology | 0 | 937 |
 | InSiliBio We use innovating solutions to test molecules through original bioinformatic methods. Our proposed methods are fully eth InSiliBio is a revolutionary contract research organization (CRO). We use innovating solutions to test molecules through original bioinformatic methods. Within the perspective of developing novel products and formulations, cosmetic, pharmaceutic and food companies undertake long research (up to several years), with expensive investments. These experiments often provide only fragmented information. These trials are sometimes being conducted on living organisms (animals, human cell etc. ), which are increasingly questioned from an ethical standpoint. Our proposed methods are fully ethical, fast, reliable and cost-effective. Our … 16 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 20 | 8 |
 | Ricoh Biosciences Transform how you model human biology. Ricoh Biosciences is a global leader in biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human biology and accelerating … 74 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 26 |
 | Elektrofi Formulating the Future of BiologicsTM Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from life-changing medicines. Our breakthrough hyper concentration microparticle technology platform, HyperconTM, resolves the limitations associated with intravenously delivered biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, we create, develop, and commercialize subcutaneous biologic therapies in collaboration with strategic partners. We believe a patient-centered healthcare approach can lead to a healthier world. We are … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 96 |
 | Editas Medicine What If You Could Repair Broken Genes? What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. We are a vibrant company full of hope, possibilities, and a belief that, working together as One … 26 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 8 | 228 |
 | Kolibri Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech 138 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 14 | 13 |
 | Allogenica "Designs the immunotherapy of tomorrow" At Allogenica, we are transforming cell therapies for a healthier tomorrow. Our mission is to disrupt the treatment landscape for cancer, rare diseases, and autoimmune disorders. We're developing a breakthrough cell therapy platform with the potential to: • Replace transplants: Providing less invasive, accessible alternatives for thousands of patients who currently have limited treatment options. • Expand access for all: With predictable safety and efficacy, we aim to make cell therapies available to a a broader patient population. • Dramatically reduce costs: By streamlining production, we aim to significantly lower the cost of cell therapies, … Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 17 | 8 |
 |  PlateletBio Allogeneic Cell Therapy Platform that Leverages Natural Platelet Biology PlateletBio is an allogeneic cell therapy company focused on platelet biology. We are pioneers, discovering a new category in therapeutics. Our approach is one-of-a-kind, recreating nature’s legendary delivery cell. In doing so, we’re developing a cell therapy empowered to tackle previously unmet medical challenges. biotechnology, platelets, and drug discovery 121 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 4 |
 | SQZ Biotechnologies Unlocking the full potential of cell therapies for patients around the world SQZ Biotechnologies is a clinical-stage biotechnology company focused on unlocking the full potential of cell therapies to benefit patients with cancer, autoimmune and infectious diseases. The company’s proprietary Cell Squeeze® technology offers the unique ability to deliver multiple biological materials into many patient cell types to engineer what we believe can be a broad range of potential therapeutics. Our goal is to create well-tolerated cell therapies that can provide therapeutic benefit for patients and improve the patient experience over existing cell therapy approaches. With accelerated production timelines under … 83 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 18 |
 | Formation Bio Bringing new treatments to patients faster and more efficiently. Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program. 174 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 179 |
 | TissueGen, Inc. TissueGen is a developer of next generation drug delivery technologies. TissueGen solves for unmet needs through the development of transformative drug delivery technologies that reduce treatment burden and improve clinical outcomes. We create life changing treatment modalities for patients and their caregivers, treating both acute and chronic conditions. 79 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 11 |
 | Chromodynamics Taking the guesswork out of drug development At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis 249 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 8 |
 | Leads To Development An expert team helping biotechs bring their drugs to and through clinical trials as efficiently as possible. Your expert team from concept to clinic. At Leads to Development, we use our knowledge and expertise to help biotechs bring their drugs to and through clinical trials as efficiently as possible, delivering value for companies and life-changing outcomes for patients. With decades of experience, more than 180 projects under our belt throughout Europe and the US, and a 100% success rate in obtaining clinic trial authorisations, our team provides comprehensive end-to-end support across all areas of new drug development. Our backgrounds are … 107 similar entities Type: SMB Startup Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 18 |
 | Outpace Bio Revolutionizing Cell Therapy with Protein Design Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLastTM), recruit a productive immune response in the tumor microenvironment (OutSmartTM), and achieve the potency (OutSpacersTM), specificity (Co-LOCKRTM), and safety (EGFRoptTM) necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 71 |
 | Cell BioEngines, Inc ‘Off-the-Shelf’ Curative Cell Therapies About Us: Cell BioEngines, Inc., founded in Dec 2022, is a clinical-stage biotech company focused on developing allogeneic 'off-the-shelf' stem cell and its derived therapies as ‘drugs’ for human disease treatment. Human body is made of ~37.2 trillion of functional cells and many incurable health problems occur due to irreversible damage to these cells. Our vision is to achieve a universal stem cell foundation platform where we can precisely generate any desired human cell state on demand and at scale, to repair or replace damaged tissue. The company utilizes a "plug-and-play" epigenetic regulatory platform to convert … 63 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 4 |
 | Sarcura Powering New Possibles in Cell Therapy Manufacturing Cell therapy has transformed cancer treatment, yet the hurdles of manufacturing patient-derived cell therapies remain a formidable challenge for the industry. Quality and scalability problems lead to high therapeutic costs and limit access to those life-saving treatments. By harnessing the power of cutting-edge semiconductor technologies, including silicon photonics seamlessly integrated into microfluidic cartridges, Sarcura is orchestrating a transformative shift. Central to Sarcura's mission is the creation of fully automated manufacturing systems endowed with real-time process and product control. This pioneering platform promises to usher in a new era of cost-effective and secure cell … 18 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 19 |
 | invIOs INNOVATIVE IMMUNO-ONCOLOGY Developing tomorrow's cancer therapies. Today. invIOs is a private biotech company focusing on discovery and development of novel cancer therapeutics that empower and educate the immune system to fight cancer. We leverage our deep expertise in immune-system activation to advance a focused pipeline of individualized and targeted approaches against solid tumors. Our focus is on earlier-stage development, with a sweet spot in bringing assets through discovery and pre-clinical development and into clinical trials. We launched in 2022 as a spin-out bundling the innovative oncology assets of APEIRON Biologics. Our highly motivated team of 35 people has deep expertise across the … 162 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 22 |
 | Cherry Biotech Alternative to Animal Testing for Drug Development Cherry Biotech is a biomedical technology (Organ on Chip) company that develops instruments for drug discovery and personalised medicine. Its mission is to replace animal testing by reconstructing human tissue (Organoids) in vitro for drug testing. Cherry Biotech's CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates. By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotech's proprietary CUBIX technology is the only solution that can convert … 57 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 17 | 21 |
 | Bioxis Pharmaceuticals #BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid 303 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology | 5 | 28 |
 | Neo-Bionica We turn medical devices into clinical reality Neo-Bionica bridges the gap between research and the clinic, providing world-class engineering expertise and links to leading clinicians to create life changing medical device solutions. Offering end-to-end medical device prototype development, from initial concept and rapid prototyping, to pre-clinical testing and first-in-human prototypes for clinical trials 120 similar entities Type: Startup Activities: deeptech healthtech biotech manufacturing Technologies: Synthetic Biology | 1 | 16 |
 | AB Science AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. We are innovators and scientific entrepreneurs in the field of life science. Our group is specialized in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical needs in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. Our pipeline is both in Human and Veterinary medicine. Our drugs are … 95 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 19 |
 | Turbine Turbine is virtualizing biological experiments with AI to accelerate discovery and clinical decisions. Turbine is virtualizing experiments with AI to accelerate discovery and clinical decisions. We’ve spent the last decade building virtual disease models that we believe are second only to the patient in predicting drug response. By simulating how cells and tissues behave under treatment, Turbine helps pharma identify the right therapeutic ideas smarter and faster, cutting years of dead-end research and reducing Phase II failure caused by poor efficacy. Scientists can now run billions of virtual experiments to uncover risk, design smarter trials, and scale decisions across entire … 176 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology | 9 | 100 |
 | Scaleo Medical SCALEO® Medical conceptualizes, develops and manufactures high-tech CE certified medical devices. Our goal is to build a successful and high technology company in the medical field, providing the best care and effective product solutions for the nursing staff and the patients. SCALEO Medical invents, develops and manufactures innovative products in the fields of patient transfer and hygiene, respiratory and medical weighing equipments. We are committed to helping our patients by developing safer and more effective products for more specialized care. We want to highlight quality products and references that will convince by their efficiency and reliability. We are committed to … 69 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 2 | 42 |
 | Newcells Biotech Ltd In vitro models to accelerate clinical translation We’re here to accelerate your therapy’s journey through the complexities of drug discovery and development. Putting innovation at the forefront of our capabilities, industry-leading experts help you confidently and proactively answer critical questions around the safety and efficacy of your product with our gold-standard in vitro models. By harnessing the power of predictive data, we navigate this crucial step efficiently and cost-effectively to maximise the potential of your therapy achieving clinical and market success. By combining our unique expertise with cutting-edge technologies, we’ve created predictive in vitro models that offer targeted solutions to … 45 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 37 |
 | MicroBrain Biotech Make your Own Neuronal Network At MicroBrain Biotech, our mission is to revolutionize drug development by embracing ethical and cruelty-free practices, putting humanity at the center of our work, and relentlessly pursuing groundbreaking discoveries. We are committed to creating innovative solutions that improve the quality of life for patients and their families, while treating all living beings with compassion and respect. Through collaboration, scientific excellence, and a commitment to sustainability, we aim to leave a lasting positive impact on the world of healthcare and beyond. Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 0 | 4 |
 | Mereo BioPharma Mereo BioPharma is a clinical-stage company focused on developing & commercialising rare disease & oncology treatments. Welcome to Mereo BioPharma, we are an agile biopharmaceutical company, focused on finding and bringing to market therapies that will improve the lives of people living with a rare disease. We are driven by a true understanding of the critical nature of our mission. We harness the power of science; with our knowledge of the rare diseases we seek to treat and deep relationships with all our stakeholders to create new therapeutic possibilities for people who need them. We do this in a focused … 35 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 46 |
 | TransCure bioServices Leading CRO in preclinical research with cutting-edge humanized mouse models for drug development. Rethinking preclinical research - with your goals in mind. TransCure bioServices accelerates drug development by delivering the right models, the right data, with the right partnership mindset. Our advanced humanized mouse models provide robust, translational in vivo results to guide decision-making in: • Oncology (Human CDX, Human PDX, Syngeneic Models) • Inflammatory diseases (IBD, MASH, GvHD, Lung Inflammation) • Infectious diseases & toxicity (HIV, HBV, Immunotoxicity, Hepatotoxicity) You know your drug. We know how to test it. Every study is co-designed with your team to fit your … 56 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics | 4 | 75 |
 | Antion Biosciences SA Re-engineering biology enabling the next generation of cell and gene therapies Antion Biosciences is a Swiss biopharmaceutical company developing novel gene and gene-modified cell therapies tools. Antion has developed a proprietary gene engineering technology with unmatched versatility to overcome key challenges facing cell and gene therapy. Our patent-protected technologies are versatile, highly effective and broadly applicable to various therapeutic areas. We actively explore collaborations and partnering opportunities to out-license our proprietary technologies. Gene and Cell therapies and Genetic engineering 70 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 11 |
 | Infinitopes Preventing deaths from cancer metastases Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival. 293 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 34 |
 | Inoviem Scientific Creative Technologies for Efficient Therapeutics, Precision medicine Inoviem Scientific is a private Bioanalytical company which delivers enabling information to secure drug discovery programs and to take informed decision by closing the gap between preclinical and clinical development. We reconcile translational pharmacology and human physiology by using fresh patient material from the target cohort, embracing the complexity of human diseases. Inoviem's enabling technologies are working in pathological conditions to get the treatment in development to the right patient. Our indication-agnostic access to patients combined with innovative label-free platforms deliver Target identification and validation, targets & Mode of Action deconvolution, patient stratification, … 82 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 8 |
 | Medical Device Engineering MEDICAL DEVICE ENGINEERING S.A.S to bring innovators the missing link in the development of their medical devices. We created MEDICAL DEVICE ENGINEERING S.A.S to bring innovators the missing link in the development of their medical devices and disposables. The concept of your therapy, or surgery has been proven from the medical point of view (PoC) and you need a device? Or you may simply have an idea and do not know where to start to make it concrete? Our Philosophy: A team composed of both Scientists & Engineers (plastics processing) to better understand each other, and to make … 63 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology | 0 | 8 |
 | Cell-Easy Your Cell-Therapy Specialized CDMO Cell-Easy is a CDMO specialized in Cell Therapy. We support biotech, pharma, and public institutions with GMP development and manufacturing. Our mission: accelerate your Cell Therapy’s path to market, with patient access as our priority. ATMPs are not conventional biologics — they are living drugs. Our team brings hands-on expertise in cell culture across all cell types, engineered or not, addressing challenges in development, GMP manufacturing, and QC. Beyond core CDMO services — process diagnostics, development, GMP production, cell banking, cryostorage, and delivery — we also support sourcing of human biological materials and clinical trial setup, … 80 similar entities Type: Startup Activities: biotech healthtech manufacturing Technologies: Synthetic Biology | 1 | 35 |
 | Greiner Bio-One International making a difference Greiner Bio-One: Innovative solutions for your hospitals, laboratories and research facilities We specialize in the development, production and distribution of high-quality plastic products for laboratories worldwide. As a reliable technology partner, we support hospitals, research institutions, laboratories as well as the diagnostic, pharmaceutical and biotechnology industries with customized solutions. Our focus: ☑ Preanalytics: We are setting new standards in safety and efficiency with innovative collection systems for blood, urine and saliva sampling. Our customized digital solutions (Greiner eHealth Technologies) optimize processes and increase patient safety in laboratories and medical practices. ☑ BioScience: We offer highly specialized products … 52 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 2 | 609 |
 | Astraveus We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing 427 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 68 |
 | Mesenbio Using mesenchymal stem cells to produce therapeutically meaningful extracellular vesicles. We are a recently incorporated limited company, spun out from the University of York from the Genever lab (www.geneverlab.info), which has over 20 years of experience in cell biology and regenerative medicine. We focus on musculoskeletal regeneration using mesenchymal stem cells (MSCs), with a view to translate our body of work into cutting edge therapeutics. Our current focal point is the field of extracellular vesicles (EVs), which have recently gained substantial traction as a next-generation therapeutic modality. We believe that current approaches have room for improvement in terms of consistency … 14 similar entities Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology | 3 | 10 |
 | Kiyatec Inc. Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and … 109 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 15 |
 | Relation Discovering the relationships at the heart of biology to cure disease. We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select … 77 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 17 | 100 |
 | Cellarity Rewriting the rules of drug creation Cellarity is fundamentally redesigning the way drugs are created. By shifting the focus from a single target to the underlying cellular dysfunction, the company unravels the complexity of disease biology to create medicines that are out of reach with the target-based drug discovery approach. Founded by Flagship Pioneering in 2017, Cellarity has developed a platform that utilizes proprietary AI models trained on over 30 million single cell transcriptomes to uncover novel actionable biology and create non-intuitive drug candidates in a vast array of diseases. The company currently has programs ongoing in several disease areas … 281 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 4 | 92 |
 |  Tirecat Health Fighting chronic and fatal diseases Tirecat Health is a company developing a family of novel polymers with amazing potential in the healthcare field. We are propelled with purpose to fight chronic and fatal diseases affecting patients worldwide using our revolutionary technology to improve their quality of life. In order to make this purpose a reality, the company is preparing to move towards the clinical phase to demonstrate the astonishing results seen in preclinical trials. 114 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 2 |
 | 10x Genomics Powering researchers’ insights with innovative single cell, spatial biology, & in situ tools. 🧬🔬 Cells are the basic unit of life. They power everything we do, and unlocking their secrets is the key to advancing our knowledge of every facet of biology, from development to disease. Our single cell, spatial, and in situ tools enable researchers to answer pressing questions about cells and their functional contributions to oncology, immunology, neuroscience, and much more—as evidenced by more than 5,500 publications citing our technology. We are dedicated to building the best products, delivering the best customer experience, and creating the best team … 20 similar entities Type: SMB Activities: industry 4.0 it services Technologies: Synthetic Biology | 5 | 2,238 |
 | Celltrion Inc Celltrion is a leading biopharmaceutical company that specializes in research, development and manufacturing of innovative therapeutics. We are committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. We have been at the forefront of biotherapeutic development uncovering new ways of targeting the drivers of disease by creating next-generation biologics and small molecule products. For additional information on our guidelines, please visit: http://tinyurl.com/bdh9bxs9 To transform possibility into a reality by promoting the health and welfare of mankind. We thrive to meet the needs of people who previously had limited access to advanced therapeutics. 117 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 3 | 1,632 |
 | LiveDrop Bio We create all-in-one instruments that make high-throughput single-cell workflows easy thanks to droplet microfluidics At LiveDrop, we develop, build, and sell cutting-edge instruments and methods for high-throughput screening of biological cells and organisms—down to the single-cell level—using microfluidic droplets. Our solutions enable faster, more precise screenings through highly efficient, fully integrated bioassays. LiveDrop’s flagship platform, ModaFlow 4L5C, revolutionises cell screening, drug discovery, and secretome analysis with unparalleled speed and precision. It supports a wide range of applications, including monoclonal antibody discovery, single-cell secretome-based bioassays, high-throughput spheroid manufacturing for drug testing, directed evolution of microbes, and enzyme discovery. We value collaboration … 60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 17 |
 | MicroOmix We give access to the pulse of life Unlocking the Future of Cell Screening with Groundbreaking Innovation MicroOmix is a pioneering startup powered by patented technology from the CNRS and the University of Strasbourg, setting a new standard in high-throughput cell screening. Our cutting-edge platform analyzes cells based on the molecules they secrete, with a level of precision and resolution that is unrivaled. Secreted molecules are at the heart of critical biological processes—driving immune responses, cell migration, tissue regeneration, and differentiation. Emerging research reveals their pivotal role in disease progression and therapeutic effectiveness, but until now, accessing these insights has … 56 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 5 |
 | Swiss Rockets AG Swiss Rockets: Innovating breakthrough medicines and transforming healthcare globally. The Swiss Rockets mission is to deliver outstanding results for patients, inventors, and investors. Founded in 2018 in Basel, Swiss Rockets is implementing a paradigm shift in healthcare. Cancer patients will benefit from new treatment therapies developed using innovative and disruptive methods. The Swiss Rockets team combines the necessary specialist knowledge and experience to efficiently and sustainably break new ground in cancer medicine. We aim to set new paradigms in healthcare. Disruptive innovation in everything we do will allow us to deliver breakthrough treatments to patients with cancer. We conduct our … Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 0 | 32 |
 | Bioscibex At Bioscibex, we are redefining bioprocessing with innovative single-use bioreactor solutions tailored for modern biologics and cell therapy manufacturing. Our mission is to empower researchers and manufacturers with tools that simplify processes, enhance scalability, and improve efficiency. 262 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 4 | 4 |
 | mo:re The efficient alternative to animal studies Your new teammate in the lab! Our lab platform takes over tedious and error-prone manual tasks in 3D cell culture, aiming to replace animal studies. A standardised repository of protocols lets you set up new experiments within minutes. Our AI-based quality control provides real-time transparency on the state of your cell culture, allowing you to worry less and make well-informed decisions. Automation, Biotechnology, Hydrogels, Cell Culture, and Organoids 65 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I. Robotics | 2 | 12 |
 | Nagi Bioscience in vivo testing at the in vitro scale At Nagi Bioscience, we develop cutting-edge biological testing solutions enabling scientists to generate the insights they need to fuel life-changing discoveries in a faster, more efficient, and ethical way. Our pioneering Organism-on-Chip platform, SydLabTM One, seamlessly integrates into existing lab environments, enabling scientists to enhance efficiency, accuracy, and reproducibility like never before. By combining this innovative technology with our team’s expertise, we deliver customer-focused solutions that empower scientists to advance research and drive scientific thinking forward. #inwormwetrust Microfluidic technology, Drug Screening, Pre-clinical studies, Lab Automation Technology, Safety and Efficacy, Toxicology, AI, C. … 187 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 49 |
 | TRON-Mainz Science in Translation - We put inspiration into practice, finding viable solutions to complex challenges. Our mission is to turn scientific breakthroughs into progress for patients. TRON is a non-profit research institute that pursues new diagnostics and drugs for the treatment of cancer and other diseases with a high medical need. We aim to bridge the gap between fundamental science at universities and market-oriented research in the pharmaceutical industry. We turn innovative scientific concepts into treatments ready for clinical testing, thereby accelerating the translation of discoveries into new diagnostics and therapies for patients. We focus our transdisciplinary competencies in genomics … 122 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 195 |
 | Century Therapeutics, Inc Harnessing the power of adult stem cells to develop curative therapies for cancer and autoimmune diseases Our genetically engineered, iPSC-derived cell products are designed to specifically target hematologic and solid tumor cancers, with a broadening application to autoimmune diseases. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of … 100 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 167 |
 | Molecular Devices Advancing Discovery Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over … 49 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 731 |
 | Limula Cell & Gene Therapy: Automated. Scalable. Accessible Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics. Bioproduction, Immunooncology, Cell therapy, Biotechnolgoy, Manufacturing, and CAR-T 132 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 7 | 25 |
 | bit.bio The Cell Coding Company bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable … 62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 164 |
 | Locate Bio Ltd Reshaping rhBMP-2 Perspectives Relieving suffering and improving quality of life with next-generation orthobiologics. Regenerative Medicine, Biomaterials, Medical devices, Drug delivery, biotechnology, BMP2, Programmed Drug Release, and Instructive Tissue Scaffolds 192 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 24 |
 | Hesperos Inc. The Human-on-a-Chip Company Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Bringing together biologists, surface chemists, and engineers, our team is producing some of the world's most advanced organs-on-a-chip platforms. From gene expression to electrophysiology, we recreate key components of organs in an interconnected, functional system. Chemically patterned microchips enable real-time, non-invasive monitoring of organ function where we use sophisticated measurement techniques to detect minute changes. This breakthrough technology enables unprecedented visibility into specific disease states and how the … 37 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 59 |
 | Phacilitate Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences 197 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 21 | 19 |
 | HHC medical Revolutionizing drug delivery HHC medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation. Drug Delivery, Genetic therapies, and Enabling life-altering therapies 408 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 2 | 47 |
 | MD Start MD Start is a fund, a team of entrepreneurs and an incubator combined, aimed at transforming innovative ideas into medical realities. Our mission is to incubate medical device innovations to the point where proof-of-principle in patients is demonstrated, allowing for interest from traditional investors and our continued funding. Our team operates the projects and new companies to bridge the gap between science and clinical experience. We source innovations that are too early for large corporate or venture investors. These inventions arise from clinicians all over the world who do not wish to become entrepreneurs Our ambition is to turn these … 95 similar entities Type: Incubators & VCs SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 4 |
 | Ascend Advanced Therapies Ascend is an advanced therapy development partner with a flexible platform featuring industry-leading analytics. Ascend is gene to GMP partner with deep expertise in advanced therapy development and commercialization. We offer unparalleled collaboration backed by expertise while working to develop your products from the bench through the clinic and beyond. Let’s build the future of advanced therapies together! 59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 164 |
 | Samsara Therapeutics Treating Neurodegenerative Disease by Restoring Autophagy At Samsara Therapeutics, we’re on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases. Our innovative approach aims to delay the progression of several debilitating conditions, offering new possibilities for patients and their families. biotechnology, biopharmaceuticals, rare disease, neurodegeneration, longevity, drug discovery, and drug development 159 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 19 |
 | PepGen Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies. Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders. Biotechnology, Chemistry, Biology, Bioscience, Life sciences, and Therapeutics 435 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 75 |
 | ZEBRA MEDICAL Care without compromise. We go beyond the conventional role of providing medical devices. Medical device manufacturer and distributor of specialised products mainly in the fields of oncology, pain management, ultrasound and cellAED 195 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 21 |
 | Just - Evotec Biologics Designing and applying innovative technologies to dramatically expand global access to biotherapeutics. Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is … 172 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 654 |
 | eXmoor Pharma Integrated CDMO & Consultancy | Cell & Gene Therapy Experts | From CMC Strategy to GMP Manufacturing & Facility Design eXmoor Pharma is the only integrated UK cell and gene therapy CDMO with consultancy expertise embedded at every stage of your journey, from early-phase strategy through GMP manufacturing to commercialisation. For over 20 years, we have provided specialised CMC consulting, process development, and GMP clinical manufacturing to more than 170 clients. Our industry-leading scientists and strategists help biotech and pharma companies accelerate innovation while reducing risk and costs. Our purpose-built process development and GMP manufacturing facility offers end-to-end solutions across … 50 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 71 |
 | MaxCyte, Inc. Let's Build Better Cells Together We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATxTM, STxTM, GTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software protocols, … 315 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 139 |
 | Kezar Life Sciences Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be … 153 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 59 |
 | Fluicell Making tissue therapeutics possible to defeat serious disease Fluicell is transforming how we treat disease with one-of-a-kind tissue solutions for regenerative medicine and drug screening. With the groundbreaking Nexocyte platform, based on twenty years of disruptive and patent-protected R&D, we are creating new ways to target serious diseases using precision-engineered biological tissues. Our transplantable tissues have the potential to help patients living with uncurable tissue damage related to cardiac, pulmonary, metabolic, kidney and other diseases. Fluicell’s first ambitious goal is to develop transplantable tissues to cure type 1 diabetes, impacting the lives of millions of patients. Nexocyte-generated tissues also enable … 33 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 18 |
 | 4Tissue Shaping the future of regenerative medicine At 4Tissue, we’re pioneering the future of regenerative medicine with innovative hydrogel solutions that support natural tissue restoration. We are an innovation-led research and clinical development organization. Our mission is to redefine the boundaries of tissue reconstruction, regeneration, and anti-aging, utilizing innovative biocompatible and bioresorbable polymers platform The first product, a bioresorbable injectable hydrogel, is focused on a better cell survival and the full regeneration of adipose tissue for breast reconstruction and augmentation applications. 60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS | 1 | 11 |
 | Unicorn Biotechnologies Reclaim your weekend Built a full-stack integrated platform (hardware and software) for autonomous scientific discovery and manufacturing (aka autonomous science/scientists). We are not just scientists. We don't just engineer cells. We don't just do software. We build the hardware backbone on which science will run, and integrate it all into devices that aren't the size and cost of a house. We call our system "Emmet". Your scientific, machine learning driven, scientifically augmented co-pilot. Faster science, quicker impact without the cost. Also, no more cell culture weekend work leads to happier and more productive scientists/engineers to research, discover and build further … 22 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 14 |
 | Fitabeo Therapeutics Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology 316 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 5 |
 | Genewity B.V. Genewity is a pioneering biotech start-up focused on advanced thymus-driven therapies for immune reconstitution. Supported by the extensive business expertise of our management and advisors, we are at the forefront of developing and commercialising breakthrough therapies. With over 150 years of combined experience in immunology and gene therapy, our team is uniquely positioned to drive advancements in the field. 273 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 17 |
 | GENZ Biotechnology Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik … 165 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 1 |
 | Dompé We Embrace the Challenge in Science Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and … 82 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 26 | 1,042 |
 | Ysium Medical Innovation We provide new technological solutions for the medicine of the future. We provide new technological solutions for the medicine of the future. We merge engineering, medicine and design to create medical devices that solve real needs. 119 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 11 |
 | Agomab Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases. 134 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 49 |